Barings Emerging EMEA Opportunities PLC logo

Barings Emerging EMEA Opportunities PLC (BEMO)

Market Closed
19 Jun, 15:30
LSE LSE
860. 00
GBX
+20
+2.381%
GBX
- Market Cap
- Div Yield
154,561 Volume
840 GBX
Previous Close
Add Transaction
Day Range
815 885
Year Range
617.4 970
Want to track BEMO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

BEMO closed yesterday higher at 860 GBX, an increase of 2.381% from Thursday's close, completing a monthly increase of 4.8781% or 40 GBX. Over the past 12 months, BEMO stock gained 8.8608%.
BEMO pays dividends to its shareholders, with the most recent payment made on Feb 06, 2026. The next announced payment will be in In 1 month on Jul 24, 2026 for a total of 6.5 GBX.
The last earnings report, released on Dec 08, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Barings Emerging EMEA Opportunities PLC has completed 1 stock splits, with the recent split occurring on May 09, 2012.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on CBOE (GBX).

BEMO Chart

Barings Emerging EMEA Opportunities PLC (BEMO) FAQ

What is the stock price today?

The current price is 860.00 GBX.

On which exchange is it traded?

Barings Emerging EMEA Opportunities PLC is listed on LSE.

What is its stock symbol?

The ticker symbol is BEMO.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, no market cap data is available.

Has Barings Emerging EMEA Opportunities PLC ever had a stock split?

Barings Emerging EMEA Opportunities PLC had 1 splits and the recent split was on May 09, 2012.

Barings Emerging EMEA Opportunities PLC Profile

LSE Exchange
AU Country

Overview

EVE Health Group Limited, an entity with its roots in Australia since 2003, primarily operates in the health and wellness industry. Originally known as EVE Investments Limited, the company has rebranded itself to better reflect its commitment towards promoting health through its extensive range of products. With subsidiaries under its wing, EVE Health Group Limited has established a firm presence in the retail and distribution sector, focusing on both the domestic and international markets. Its strategic base in Subiaco, Australia, serves as the foundation for its operations, enabling it to reach a broad audience seeking health and wellness solutions.

Products and Services

  • Organic Raw Honey
  • EVE Health Group Limited provides high-quality organic raw honey, adhering to strict standards to ensure the preservation of natural nutrients and enzymes. This product targets consumers seeking natural sweeteners that also offer health benefits.

  • Raw Honey Probiotic Concentrates
  • Expanding its honey product line, the company offers raw honey probiotic concentrates. These are designed to enhance gut health by combining the natural goodness of raw honey with probiotics, catering to the growing demand for functional foods that support digestive health.

  • Contract Manufacturing Services
  • Aside from its retail products, EVE Health Group Limited extends its expertise to offer contract manufacturing services. This allows other brands to leverage EVE's manufacturing capabilities to produce their own health and wellness products, fostering a collaborative approach within the industry.

  • Online Store
  • To ensure accessibility and convenience for its customers, EVE Health Group Limited sells its products through an online store. This digital platform enables the company to reach a wider audience, providing easy access to its health and wellness solutions with just a few clicks.

Contact Information

Address: 245 Churchill Avenue, Subiaco, WA, Australia, 6008
Phone: 61 8 6465 5500